BioNTech, Pfizer begin German part of Covid-19 vaccine study | The Business Standard
Skip to main content
  • Home
  • Economy
    • Aviation
    • Bazaar
    • Budget
    • Industry
    • NBR
    • RMG
    • Corporates
  • Stocks
  • Analysis
  • World+Biz
  • Sports
  • Features
    • Book Review
    • Brands
    • Earth
    • Explorer
    • Fact Check
    • Family
    • Food
    • Game Reviews
    • Good Practices
    • Habitat
    • Humour
    • In Focus
    • Luxury
    • Mode
    • Panorama
    • Pursuit
    • Wealth
    • Wellbeing
    • Wheels
  • Epaper
    • GOVT. Ad
  • More
    • Subscribe
    • Videos
    • TBS Graduates
    • Thoughts
    • Splash
    • Bangladesh
    • Supplement
    • Infograph
    • Archive
    • COVID-19
    • Long Read
    • Interviews
    • Offbeat
    • Tech
    • Magazine
  • বাংলা
The Business Standard

Friday
September 22, 2023

Sign In
Subscribe
  • Home
  • Economy
    • Aviation
    • Bazaar
    • Budget
    • Industry
    • NBR
    • RMG
    • Corporates
  • Stocks
  • Analysis
  • World+Biz
  • Sports
  • Features
    • Book Review
    • Brands
    • Earth
    • Explorer
    • Fact Check
    • Family
    • Food
    • Game Reviews
    • Good Practices
    • Habitat
    • Humour
    • In Focus
    • Luxury
    • Mode
    • Panorama
    • Pursuit
    • Wealth
    • Wellbeing
    • Wheels
  • Epaper
    • GOVT. Ad
  • More
    • Subscribe
    • Videos
    • TBS Graduates
    • Thoughts
    • Splash
    • Bangladesh
    • Supplement
    • Infograph
    • Archive
    • COVID-19
    • Long Read
    • Interviews
    • Offbeat
    • Tech
    • Magazine
  • বাংলা
FRIDAY, SEPTEMBER 22, 2023
BioNTech, Pfizer begin German part of Covid-19 vaccine study

Coronavirus chronicle

Reuters
07 September, 2020, 06:05 pm
Last modified: 07 September, 2020, 08:36 pm

Related News

  • Pfizer's updated Covid shot effective against 'Eris' variant in mice study
  • US FDA approves Pfizer's blood cancer therapy
  • Tornado damage to Pfizer plant unlikely to cause major drug supply shortages: FDA
  • US CDC still looking at potential stroke risk from Pfizer bivalent Covid shot
  • BioNTech starts human trial to test malaria vaccine

BioNTech, Pfizer begin German part of Covid-19 vaccine study

Germany's vaccines regulator, the Paul Ehrlich Institute, gave the approval for the Phase 2/3 trial of the experimental vaccine known as BNT162b2, BioNTech and its partner Pfizer said in a statement

Reuters
07 September, 2020, 06:05 pm
Last modified: 07 September, 2020, 08:36 pm
File Photo: Small bottles labeled with a "Vaccine Covid-19" sticker and a medical syringe are seen in this illustration taken April 10, 2020. Reuters/Dado Ruvic/Illustration/File Photo
File Photo: Small bottles labeled with a "Vaccine Covid-19" sticker and a medical syringe are seen in this illustration taken April 10, 2020. Reuters/Dado Ruvic/Illustration/File Photo

Biotech firm BioNTech said on Monday it widened an ongoing pivotal global study of its Covid-19 vaccine candidate to include testing in its home country of Germany.

Germany's vaccines regulator, the Paul Ehrlich Institute, gave the approval for the Phase 2/3 trial of the experimental vaccine known as BNT162b2, BioNTech and its partner Pfizer said in a statement.

The global trial was initiated in July, with a view to including about 120 sites globally and seeking up to 30,000 participants in total.

More than 25,000 participants have been enrolled, BioNTech said, adding it remained on track to seek approval for BNT162b2 as early as next month.

Top News

Pfizer / BionTech

Comments

While most comments will be posted if they are on-topic and not abusive, moderation decisions are subjective. Published comments are readers’ own views and The Business Standard does not endorse any of the readers’ comments.

Top Stories

  • File photo of State Minister for Foreign Affairs Shahriar Alam. Photo: UNB
    Nothing to lose from visa restrictions: Shahriar Alam
  • US Assistant Secretary of State Donald Lu. Photo: Collected
    Visa restrictions imposed on law enforcers, ruling party, and opposition: US Envoy Donald Lu
  • Photo: TBS
    12 hours after heavy rain, many places still waterlogged

MOST VIEWED

  • Foodpanda up for sale in most Asian markets. What about Bangladesh?
    Foodpanda up for sale in most Asian markets. What about Bangladesh?
  • Bangladesh-Myanmar visa exemption reinstated
    Bangladesh-Myanmar visa exemption reinstated
  • Rain water entered in many roadside shops in the city. This photo was taken from a shop in Zafrabad, West Dhanmondi on Thursday (21 September). Photo: TBS
    Heavy rain causes severe waterlogging in Dhaka
  • Photo: TBS
    Chattogram Zoo acquires hippos, gives tigers to Rangpur Zoo
  • Areas around the Dhanmondi 8 bridge submerged in rainwater on Thursday (21 September). Photo: TBS
    4 die from electrocution as live wire falls in rainwater in Mirpur
  • An aerial view of the Matarbari coal-based power plant in Cox's Bazar's Maheshkhali upazila. Photo: TBS
    Matarbari deep sea port channel handed over to Ctg Port Authority

Related News

  • Pfizer's updated Covid shot effective against 'Eris' variant in mice study
  • US FDA approves Pfizer's blood cancer therapy
  • Tornado damage to Pfizer plant unlikely to cause major drug supply shortages: FDA
  • US CDC still looking at potential stroke risk from Pfizer bivalent Covid shot
  • BioNTech starts human trial to test malaria vaccine

Features

This photo captured from in front of the Institute of Engineers around 11:30pm Thursday shows the severe waterlogging on Dhaka road. Photo: TBS

A swim through the city

2h | Features
Photo: Akif Hamid

Celebrating the Dhaka Elevated Expressway with Volkswagen Club Bangladesh

3h | Wheels
The Runner Skooty has become a popular choice for people looking to beat the scary city traffic, especially for its low maintenance and practical features. Photo: Akif Hamid

Runner Skooty 110: A versatile companion for urban mobility

4h | Wheels
X-Files: 30 years of the truth being out there

X-Files: 30 years of the truth being out there

7h | Features

More Videos from TBS

After almost two months, the Ukrainian grain ship left the Black Sea port

After almost two months, the Ukrainian grain ship left the Black Sea port

1d | TBS World
Revenue collection rises 15% in first two months of FY24

Revenue collection rises 15% in first two months of FY24

1d | TBS Economy
Fans call for Amir’s inclusion after Naseem Shah's injury

Fans call for Amir’s inclusion after Naseem Shah's injury

1d | TBS SPORTS
Chittagong University walls painted in graffiti

Chittagong University walls painted in graffiti

2h | TBS Stories
EMAIL US
[email protected]
FOLLOW US
WHATSAPP
+880 1847416158
The Business Standard
  • About Us
  • Contact us
  • Sitemap
  • Privacy Policy
  • Comment Policy
Copyright © 2023
The Business Standard All rights reserved
Technical Partner: RSI Lab

Contact Us

The Business Standard

Main Office -4/A, Eskaton Garden, Dhaka- 1000

Phone: +8801847 416158 - 59

Send Opinion articles to - [email protected]

For advertisement- [email protected]